Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for JAZZ

Stock Name	Jazz Pharmaceuticals PLC
Ticker	JAZZ(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	IE00B4Q5ZN47

Show aggregate JAZZ holdings

News associated with JAZZ

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $185.00: Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target hoisted by The Goldman Sachs Group from $162.00 to $185.00 in a research report report published on Friday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently commented on […] - 2025-09-01 02:59:05
Implied FSMD Analyst Target Price: $49: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:25:46
Brokerages Set Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Target Price at $181.43: Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year target […] - 2025-08-19 03:06:58
Swiss National Bank Trims Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Swiss National Bank decreased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.6% in the first quarter, Holdings Channel reports. The firm owned 111,300 shares of the specialty pharmaceutical company’s stock after selling 4,100 shares during the period. Swiss National Bank’s holdings in Jazz Pharmaceuticals were worth $13,818,000 at the end of […] - 2025-08-15 05:24:55
Vanguard Group Inc. Has $747.06 Million Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Vanguard Group Inc. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 0.3% in the first quarter, Holdings Channel reports. The institutional investor owned 6,017,403 shares of the specialty pharmaceutical company’s stock after selling 18,780 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Jazz Pharmaceuticals worth $747,061,000 at the […] - 2025-08-13 06:14:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Purchased by PNC Financial Services Group Inc.: PNC Financial Services Group Inc. lifted its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 5,128 shares of the specialty pharmaceutical company’s stock after acquiring an additional 379 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Jazz Pharmaceuticals were worth […] - 2025-08-13 04:38:53
Cetera Investment Advisers Purchases 444 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Cetera Investment Advisers increased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 4.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,536 shares of the specialty pharmaceutical company’s stock after purchasing an additional 444 shares during the quarter. Cetera Investment […] - 2025-08-11 04:18:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Allianz Asset Management GmbH: Allianz Asset Management GmbH lessened its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 24.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 58,745 shares of the specialty pharmaceutical company’s stock after selling 19,447 shares during the quarter. […] - 2025-07-28 04:36:57
Y Intercept Hong Kong Ltd Grows Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Y Intercept Hong Kong Ltd increased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 269.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 9,721 shares of the specialty pharmaceutical company’s stock after acquiring an additional 7,090 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Jazz Pharmaceuticals […] - 2025-07-25 06:11:00
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives $181.71 Consensus Price Target from Analysts: Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average […] - 2025-07-25 04:35:13
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by Xponance Inc.: Xponance Inc. raised its position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,594 shares of the specialty pharmaceutical company’s stock after acquiring an additional 648 shares during the […] - 2025-07-17 07:42:48
Jazz Pharmaceuticals (NASDAQ:JAZZ) Now Covered by Deutsche Bank Aktiengesellschaft: Analysts at Deutsche Bank Aktiengesellschaft initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $152.00 price target on the specialty pharmaceutical company’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential […] - 2025-07-17 06:19:01
Cerity Partners LLC Acquires 4,744 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Cerity Partners LLC raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 14.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 37,949 shares of the specialty pharmaceutical company’s stock after acquiring an additional 4,744 shares during the quarter. Cerity Partners LLC’s holdings in Jazz Pharmaceuticals were worth $4,711,000 at […] - 2025-07-17 05:00:57
State of Michigan Retirement System Has $1.80 Million Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): State of Michigan Retirement System increased its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,504 shares of the specialty pharmaceutical company’s stock after buying an additional 200 shares […] - 2025-07-15 06:28:18
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by OneDigital Investment Advisors LLC: OneDigital Investment Advisors LLC grew its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,932 shares of the specialty pharmaceutical company’s stock after buying an additional 377 shares during […] - 2025-07-11 07:30:53
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Teacher Retirement System of Texas: Teacher Retirement System of Texas reduced its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,470 shares of the specialty pharmaceutical company’s stock after selling 1,902 shares during the quarter. Teacher Retirement System […] - 2025-07-11 05:14:57
Vontobel Holding Ltd. Lowers Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Vontobel Holding Ltd. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 15.5% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 3,577 shares of the specialty pharmaceutical company’s stock after selling 656 shares during the period. Vontobel Holding Ltd.’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 05:30:53
Allspring Global Investments Holdings LLC Sells 489 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Allspring Global Investments Holdings LLC trimmed its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.1% during the first quarter, Holdings Channel.com reports. The fund owned 15,129 shares of the specialty pharmaceutical company’s stock after selling 489 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 04:32:49
Envestnet Portfolio Solutions Inc. Buys 1,223 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Envestnet Portfolio Solutions Inc. raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 38.9% during the 1st quarter, HoldingsChannel.com reports. The fund owned 4,369 shares of the specialty pharmaceutical company’s stock after buying an additional 1,223 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Jazz Pharmaceuticals were worth $542,000 at […] - 2025-06-27 05:08:51
15,296 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Ritholtz Wealth Management: Ritholtz Wealth Management bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,296 shares of the specialty pharmaceutical company’s stock, valued at approximately $1,899,000. A number of other […] - 2025-06-17 07:00:52
Yousif Capital Management LLC Decreases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Yousif Capital Management LLC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 12,644 shares of the specialty pharmaceutical company’s stock after selling 342 shares during the quarter. Yousif Capital Management LLC’s holdings in Jazz Pharmaceuticals were worth $1,570,000 as of […] - 2025-06-17 05:08:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 22.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,102 shares of the specialty pharmaceutical company’s stock after purchasing an additional 743 shares during […] - 2025-06-13 04:34:51
2,265 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by Merit Financial Group LLC: Merit Financial Group LLC bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 2,265 shares of the specialty pharmaceutical company’s stock, valued at approximately $281,000. Several other large investors have also recently modified their holdings of JAZZ. IFP Advisors Inc bought […] - 2025-06-12 05:32:55
Wedmont Private Capital Sells 903 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Wedmont Private Capital trimmed its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 13.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,912 shares of the specialty pharmaceutical company’s stock after selling 903 shares during the period. […] - 2025-06-10 05:33:02
Focus Partners Wealth Invests $551,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Focus Partners Wealth bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 4,469 shares of the specialty pharmaceutical company’s stock, valued at approximately $551,000. A number of other hedge funds also recently modified their holdings of the stock. Bessemer Group […] - 2025-05-20 07:12:52
How The Pieces Add Up: IJH Headed For $69: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:47
Hsbc Holdings PLC Acquires 605 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Hsbc Holdings PLC boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 26.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,871 shares of the specialty pharmaceutical company’s stock after buying an additional 605 […] - 2025-05-09 05:34:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Townsquare Capital LLC: Townsquare Capital LLC lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 79.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,540 shares of the specialty pharmaceutical company’s stock after buying an additional 1,568 shares during the quarter. Townsquare […] - 2025-04-21 05:00:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Bank of Montreal Can: Bank of Montreal Can reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,194 shares of the specialty pharmaceutical company’s stock after selling 2,253 shares during the period. Bank of […] - 2025-04-17 05:42:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MN: Wells Fargo & Company MN lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.1% during the fourth quarter, HoldingsChannel reports. The fund owned 96,952 shares of the specialty pharmaceutical company’s stock after selling 20,063 shares during the period. Wells Fargo & Company MN’s holdings in Jazz Pharmaceuticals were worth […] - 2025-04-16 05:27:14

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc JAZZ holdings

Date	Number of JAZZ Shares Held	Base Market Value of JAZZ Shares	Local Market Value of JAZZ Shares	Change in JAZZ Shares Held	Change in JAZZ Base Value	Current Price per JAZZ Share Held	Previous Price per JAZZ Share Held
2026-01-15 (Thursday)	35,074	USD 6,003,266	USD 6,003,266	5,408	USD 936,017	USD 171.16	USD 170.81
2026-01-14 (Wednesday)	29,666	USD 5,067,249	USD 5,067,249	104	USD 265,493	USD 170.81	USD 162.43
2026-01-13 (Tuesday)	29,562	USD 4,801,756	USD 4,801,756	0	USD -36,952	USD 162.43	USD 163.68
2026-01-12 (Monday)	29,562	USD 4,838,708	USD 4,838,708	0	USD 75,383	USD 163.68	USD 161.13
2026-01-09 (Friday)	29,562	USD 4,763,325	USD 4,763,325	0	USD 26,014	USD 161.13	USD 160.25
2026-01-08 (Thursday)	29,562	USD 4,737,311	USD 4,737,311	0	USD -269,605	USD 160.25	USD 169.37
2026-01-07 (Wednesday)	29,562	USD 5,006,916	USD 5,006,916	0	USD 70,358	USD 169.37	USD 166.99
2026-01-06 (Tuesday)	29,562	USD 4,936,558	USD 4,936,558	0	USD -218,759	USD 166.99	USD 174.39
2026-01-05 (Monday)	29,562	USD 5,155,317	USD 5,155,317	0	USD 36,657	USD 174.39	USD 173.15
2026-01-02 (Friday)	29,562	USD 5,118,660	USD 5,118,660	0	USD 93,120	USD 173.15	USD 170
2025-12-31 (Wednesday)	29,562	USD 5,025,540	USD 5,025,540	744	USD 102,849	USD 170	USD 170.82

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of JAZZ by Blackrock for IE00B3VWM098

Show aggregate share trades of JAZZ

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 5,408 172.490 167.180 167.711 USD 906,981 129.16
2026-01-14 BUY 104 173.090 162.678 163.719 USD 17,027 128.99
2025-12-31 BUY 744 170.820 169.460 169.596 USD 126,179 127.51
2025-12-31 BUY 744 170.820 169.460 169.596 USD 126,179 127.51
2025-12-23 SELL -101 170.200 168.550 168.715 USD -17,040 126.56 Loss of -4,257 on sale
2025-12-03 SELL -505 169.250 166.090 166.406 USD -84,035 123.89 Loss of -21,472 on sale
2025-12-02 BUY 202 173.600 166.540 167.246 USD 33,784 123.68
2025-11-25 SELL -303 182.750 178.010 178.484 USD -54,081 122.40 Loss of -16,993 on sale
2025-11-24 BUY 386 182.270 172.190 173.198 USD 66,854 122.12
2025-11-18 SELL -1,089 182.990 169.870 171.182 USD -186,417 121.02 Loss of -54,628 on sale
2025-11-12 SELL -99 140.680 136.270 136.711 USD -13,534 120.48 Loss of -1,607 on sale
2025-11-06 BUY 696 144.970 130.792 132.209 USD 92,018 120.21
2025-11-05 SELL -960 139.790 134.500 135.029 USD -129,628 120.12 Loss of -14,315 on sale
2025-11-04 SELL -192 139.065 136.000 136.307 USD -26,171 120.02 Loss of -3,126 on sale
2025-11-03 SELL -192 138.450 136.665 136.843 USD -26,274 119.93 Loss of -3,248 on sale
2025-10-24 SELL -97 138.530 139.400 139.313 USD -13,513 119.35 Loss of -1,936 on sale
2025-10-02 BUY 99 137.210 138.150 138.056 USD 13,668 118.45
2025-09-30 BUY 198 131.800 131.930 131.917 USD 26,120 118.27
2025-09-17 BUY 967 129.540 130.870 130.737 USD 126,423 118.03
2025-08-21 SELL -94 120.530 120.920 120.881 USD -11,363 118.01 Loss of -270 on sale
2025-07-31 BUY 291 114.630 116.560 116.367 USD 33,863 118.03
2025-07-28 SELL -97 117.380 118.280 118.190 USD -11,464 118.05 Loss of -13 on sale
2025-06-30 SELL -194 106.120 108.440 108.208 USD -20,992 118.74 Profit of 2,044 on sale
2025-06-25 SELL -97 107.120 108.310 108.191 USD -10,495 118.99 Profit of 1,047 on sale
2025-06-20 SELL -194 107.510 108.790 108.662 USD -21,080 119.23 Profit of 2,051 on sale
2025-05-19 SELL -97 109.780 110.140 110.104 USD -10,680 121.31 Profit of 1,087 on sale
2025-05-15 SELL -291 106.070 107.430 107.294 USD -31,223 121.55 Profit of 4,148 on sale
2025-05-12 SELL -97 103.580 105.280 105.110 USD -10,196 122.01 Profit of 1,640 on sale
2025-05-09 SELL -97 97.780 99.980 99.760 USD -9,677 122.23 Profit of 2,180 on sale
2025-04-30 SELL -97 116.960 117.570 117.509 USD -11,398 122.94 Profit of 526 on sale
2025-04-24 SELL -194 108.980 109.230 109.205 USD -21,186 123.37 Profit of 2,747 on sale
2025-04-17 SELL -97 102.780 104.530 104.355 USD -10,122 124.47 Profit of 1,951 on sale
2025-04-15 SELL -291 102.910 104.120 103.999 USD -30,264 124.95 Profit of 6,097 on sale
2025-04-14 SELL -291 101.750 103.440 103.271 USD -30,052 125.20 Profit of 6,383 on sale
2025-04-09 SELL -388 110.120 110.500 110.462 USD -42,859 125.92 Profit of 5,998 on sale
2025-04-07 SELL -679 106.930 111.650 111.178 USD -75,490 126.41 Profit of 10,342 on sale
2025-04-04 SELL -970 110.040 117.120 116.412 USD -112,920 126.60 Profit of 9,884 on sale
2025-03-31 BUY 97 124.150 124.680 124.627 USD 12,089 126.65
2025-03-19 SELL -194 142.070 142.420 142.385 USD -27,623 125.77 Loss of -3,224 on sale
2025-03-14 SELL -582 137.960 138.200 138.176 USD -80,418 125.20 Loss of -7,554 on sale
2025-03-13 SELL -188 136.050 138.330 138.102 USD -25,963 125.04 Loss of -2,455 on sale
2025-03-12 SELL -1,921 134.160 137.510 137.175 USD -263,513 124.91 Loss of -23,560 on sale
2025-03-07 SELL -188 138.810 141.360 141.105 USD -26,528 124.33 Loss of -3,154 on sale
2025-03-06 SELL -282 136.450 140.130 139.762 USD -39,413 124.14 Loss of -4,405 on sale
2025-03-03 SELL -94 140.220 145.400 144.882 USD -13,619 123.38 Loss of -2,021 on sale
2025-02-28 BUY 3,521 143.530 143.670 143.656 USD 505,813 123.05
2025-02-26 SELL -83 144.170 148.060 147.671 USD -12,257 122.35 Loss of -2,101 on sale
2025-02-25 SELL -249 139.670 140.520 140.435 USD -34,968 122.06 Loss of -4,577 on sale
2025-02-18 BUY 415 135.390 135.700 135.669 USD 56,303 120.75
2025-02-13 BUY 83 136.820 138.270 138.125 USD 11,464 119.90
2025-02-12 BUY 83 135.440 136.550 136.439 USD 11,324 119.58
2025-02-11 BUY 249 129.980 131.500 131.348 USD 32,706 119.36
2025-02-06 BUY 747 120.070 122.040 121.843 USD 91,017 119.23
2025-01-27 BUY 83 124.390 124.830 124.786 USD 10,357 118.34
2024-12-30 BUY 415 122.970 124.600 124.437 USD 51,641 117.80
2024-12-06 BUY 332 122.590 124.100 123.949 USD 41,151 117.46
2024-12-05 BUY 83 123.140 123.820 123.752 USD 10,271 117.27
2024-12-04 BUY 415 123.450 123.570 123.558 USD 51,277 117.05
2024-11-29 BUY 415 121.590 123.180 123.021 USD 51,054 116.50
2024-11-27 BUY 332 122.640 124.710 124.503 USD 41,335 115.97
2024-11-26 BUY 83 122.790 123.600 123.519 USD 10,252 115.66
2024-11-25 BUY 1,295 124.340 128.410 128.003 USD 165,764 115.24
2024-11-21 BUY 395 125.100 125.640 125.586 USD 49,606 114.12
2024-11-20 BUY 237 119.240 119.470 119.447 USD 28,309 113.84
2024-11-18 BUY 948 117.590 122.880 122.351 USD 115,989 113.42
2024-11-12 BUY 632 127.740 128.370 128.307 USD 81,090 112.46
2024-11-08 BUY 395 123.610 123.970 123.934 USD 48,954 111.67
2024-11-07 BUY 1,185 119.080 121.240 121.024 USD 143,413 111.10
2024-11-06 BUY 158 111.550 114.120 113.863 USD 17,990 111.06
2024-10-31 BUY 79 110.030 111.800 111.623 USD 8,818 111.43
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	5,408	172.490	167.180	167.711	USD 906,981	129.16
2026-01-14	BUY	104	173.090	162.678	163.719	USD 17,027	128.99
2025-12-31	BUY	744	170.820	169.460	169.596	USD 126,179	127.51
2025-12-31	BUY	744	170.820	169.460	169.596	USD 126,179	127.51
2025-12-23	SELL	-101	170.200	168.550	168.715	USD -17,040	126.56 Loss of -4,257 on sale
2025-12-03	SELL	-505	169.250	166.090	166.406	USD -84,035	123.89 Loss of -21,472 on sale
2025-12-02	BUY	202	173.600	166.540	167.246	USD 33,784	123.68
2025-11-25	SELL	-303	182.750	178.010	178.484	USD -54,081	122.40 Loss of -16,993 on sale
2025-11-24	BUY	386	182.270	172.190	173.198	USD 66,854	122.12
2025-11-18	SELL	-1,089	182.990	169.870	171.182	USD -186,417	121.02 Loss of -54,628 on sale
2025-11-12	SELL	-99	140.680	136.270	136.711	USD -13,534	120.48 Loss of -1,607 on sale
2025-11-06	BUY	696	144.970	130.792	132.209	USD 92,018	120.21
2025-11-05	SELL	-960	139.790	134.500	135.029	USD -129,628	120.12 Loss of -14,315 on sale
2025-11-04	SELL	-192	139.065	136.000	136.307	USD -26,171	120.02 Loss of -3,126 on sale
2025-11-03	SELL	-192	138.450	136.665	136.843	USD -26,274	119.93 Loss of -3,248 on sale
2025-10-24	SELL	-97	138.530	139.400	139.313	USD -13,513	119.35 Loss of -1,936 on sale
2025-10-02	BUY	99	137.210	138.150	138.056	USD 13,668	118.45
2025-09-30	BUY	198	131.800	131.930	131.917	USD 26,120	118.27
2025-09-17	BUY	967	129.540	130.870	130.737	USD 126,423	118.03
2025-08-21	SELL	-94	120.530	120.920	120.881	USD -11,363	118.01 Loss of -270 on sale
2025-07-31	BUY	291	114.630	116.560	116.367	USD 33,863	118.03
2025-07-28	SELL	-97	117.380	118.280	118.190	USD -11,464	118.05 Loss of -13 on sale
2025-06-30	SELL	-194	106.120	108.440	108.208	USD -20,992	118.74 Profit of 2,044 on sale
2025-06-25	SELL	-97	107.120	108.310	108.191	USD -10,495	118.99 Profit of 1,047 on sale
2025-06-20	SELL	-194	107.510	108.790	108.662	USD -21,080	119.23 Profit of 2,051 on sale
2025-05-19	SELL	-97	109.780	110.140	110.104	USD -10,680	121.31 Profit of 1,087 on sale
2025-05-15	SELL	-291	106.070	107.430	107.294	USD -31,223	121.55 Profit of 4,148 on sale
2025-05-12	SELL	-97	103.580	105.280	105.110	USD -10,196	122.01 Profit of 1,640 on sale
2025-05-09	SELL	-97	97.780	99.980	99.760	USD -9,677	122.23 Profit of 2,180 on sale
2025-04-30	SELL	-97	116.960	117.570	117.509	USD -11,398	122.94 Profit of 526 on sale
2025-04-24	SELL	-194	108.980	109.230	109.205	USD -21,186	123.37 Profit of 2,747 on sale
2025-04-17	SELL	-97	102.780	104.530	104.355	USD -10,122	124.47 Profit of 1,951 on sale
2025-04-15	SELL	-291	102.910	104.120	103.999	USD -30,264	124.95 Profit of 6,097 on sale
2025-04-14	SELL	-291	101.750	103.440	103.271	USD -30,052	125.20 Profit of 6,383 on sale
2025-04-09	SELL	-388	110.120	110.500	110.462	USD -42,859	125.92 Profit of 5,998 on sale
2025-04-07	SELL	-679	106.930	111.650	111.178	USD -75,490	126.41 Profit of 10,342 on sale
2025-04-04	SELL	-970	110.040	117.120	116.412	USD -112,920	126.60 Profit of 9,884 on sale
2025-03-31	BUY	97	124.150	124.680	124.627	USD 12,089	126.65
2025-03-19	SELL	-194	142.070	142.420	142.385	USD -27,623	125.77 Loss of -3,224 on sale
2025-03-14	SELL	-582	137.960	138.200	138.176	USD -80,418	125.20 Loss of -7,554 on sale
2025-03-13	SELL	-188	136.050	138.330	138.102	USD -25,963	125.04 Loss of -2,455 on sale
2025-03-12	SELL	-1,921	134.160	137.510	137.175	USD -263,513	124.91 Loss of -23,560 on sale
2025-03-07	SELL	-188	138.810	141.360	141.105	USD -26,528	124.33 Loss of -3,154 on sale
2025-03-06	SELL	-282	136.450	140.130	139.762	USD -39,413	124.14 Loss of -4,405 on sale
2025-03-03	SELL	-94	140.220	145.400	144.882	USD -13,619	123.38 Loss of -2,021 on sale
2025-02-28	BUY	3,521	143.530	143.670	143.656	USD 505,813	123.05
2025-02-26	SELL	-83	144.170	148.060	147.671	USD -12,257	122.35 Loss of -2,101 on sale
2025-02-25	SELL	-249	139.670	140.520	140.435	USD -34,968	122.06 Loss of -4,577 on sale
2025-02-18	BUY	415	135.390	135.700	135.669	USD 56,303	120.75
2025-02-13	BUY	83	136.820	138.270	138.125	USD 11,464	119.90
2025-02-12	BUY	83	135.440	136.550	136.439	USD 11,324	119.58
2025-02-11	BUY	249	129.980	131.500	131.348	USD 32,706	119.36
2025-02-06	BUY	747	120.070	122.040	121.843	USD 91,017	119.23
2025-01-27	BUY	83	124.390	124.830	124.786	USD 10,357	118.34
2024-12-30	BUY	415	122.970	124.600	124.437	USD 51,641	117.80
2024-12-06	BUY	332	122.590	124.100	123.949	USD 41,151	117.46
2024-12-05	BUY	83	123.140	123.820	123.752	USD 10,271	117.27
2024-12-04	BUY	415	123.450	123.570	123.558	USD 51,277	117.05
2024-11-29	BUY	415	121.590	123.180	123.021	USD 51,054	116.50
2024-11-27	BUY	332	122.640	124.710	124.503	USD 41,335	115.97
2024-11-26	BUY	83	122.790	123.600	123.519	USD 10,252	115.66
2024-11-25	BUY	1,295	124.340	128.410	128.003	USD 165,764	115.24
2024-11-21	BUY	395	125.100	125.640	125.586	USD 49,606	114.12
2024-11-20	BUY	237	119.240	119.470	119.447	USD 28,309	113.84
2024-11-18	BUY	948	117.590	122.880	122.351	USD 115,989	113.42
2024-11-12	BUY	632	127.740	128.370	128.307	USD 81,090	112.46
2024-11-08	BUY	395	123.610	123.970	123.934	USD 48,954	111.67
2024-11-07	BUY	1,185	119.080	121.240	121.024	USD 143,413	111.10
2024-11-06	BUY	158	111.550	114.120	113.863	USD 17,990	111.06
2024-10-31	BUY	79	110.030	111.800	111.623	USD 8,818	111.43

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of JAZZ

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	112,073	0	208,473	53.8%
2025-09-18	174,563	0	259,899	67.2%
2025-09-17	181,867	0	321,522	56.6%
2025-09-16	144,278	295	264,733	54.5%
2025-09-15	104,621	10	235,855	44.4%
2025-09-12	204,437	0	280,698	72.8%
2025-09-11	110,769	58	388,046	28.5%
2025-09-10	95,550	0	204,768	46.7%
2025-09-09	105,946	5	218,517	48.5%
2025-09-08	114,184	73	205,785	55.5%
2025-09-05	176,466	9	300,437	58.7%
2025-09-04	217,876	0	386,092	56.4%
2025-09-03	159,099	0	265,396	59.9%
2025-09-02	245,766	1,378	345,991	71.0%
2025-08-29	188,379	0	252,582	74.6%
2025-08-28	166,386	2,760	218,636	76.1%
2025-08-27	141,870	22,558	195,620	72.5%
2025-08-26	217,585	11,530	291,596	74.6%
2025-08-25	225,170	0	314,430	71.6%
2025-08-22	135,885	193	263,628	51.5%
2025-08-21	107,180	329	288,390	37.2%
2025-08-20	145,789	0	282,575	51.6%
2025-08-19	211,546	0	381,132	55.5%
2025-08-18	136,130	58	223,196	61.0%
2025-08-15	114,778	0	190,467	60.3%
2025-08-14	125,124	0	224,730	55.7%
2025-08-13	265,703	15,414	607,343	43.7%
2025-08-12	124,715	15	276,805	45.1%
2025-08-11	149,930	0	300,250	49.9%
2025-08-08	152,810	4,111	258,684	59.1%
2025-08-07	456,871	104	781,305	58.5%
2025-08-06	788,262	31	1,198,162	65.8%
2025-08-05	177,955	42	421,699	42.2%
2025-08-04	124,630	10	224,655	55.5%
2025-08-01	144,039	4	220,460	65.3%
2025-07-31	81,903	75	163,020	50.2%
2025-07-30	70,567	18	141,254	50.0%
2025-07-29	95,304	13	189,722	50.2%
2025-07-28	86,232	41	165,168	52.2%
2025-07-25	100,335	0	159,541	62.9%
2025-07-24	104,031	10	197,575	52.7%
2025-07-23	89,333	413	211,213	42.3%
2025-07-22	245,642	4,000	510,584	48.1%
2025-07-21	115,065	22	156,579	73.5%
2025-07-18	143,324	0	210,983	67.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE